This information was published on 2021-04-15T14:04:14 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2169148 |
| (220) |
07 Apr 2021
|
| (300) |
US, 15 Oct 2020, 90/257,563
|
| (511) (510) |
Class 5
Films dissolvable in the mouth for the oral delivery of drugs, pharmaceuticals and dietary supplements to humans; Dissolvable polymer films as a base in preparations for oral, sublingual, buccal, or transmucosal delivery of pharmaceutically active ingredients; Drug delivery platform technology, namely, drug delivery agents consisting of compounds that facilitate, enhance or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability, or enhanced absorption of a wide range of pharmaceutical agents; pharmaceutical preparations, namely, oral, sublingual, buccal, or transmucosal delivery enhancement agents to facilitate, enhance, or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability or enhanced absorption of a variety of pharmaceutical agents |
| (540) | PHARMFILM |
| (550) | Word |
| (730) |
Aquestive Therapeutics, Inc.
|
| (750) |
PHILLIPS ORMONDE FITZPATRICK
|
Find out more about publications on the About page.